The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Managing Side Effects of HIV TreatmentManaging Side Effects of HIV Treatment
Rollover images to visit our other forums!
  • Email Email
  • Glossary Glossary

T-20, one drug or cocktail?
Mar 11, 2003

Hi Docs, I would like to know if the drugs that are currently being developed/researched are cocktail drugs or just single drugs e.g I've just read that T-20 is in stage 3 of trials. How many more stages before we can know whether or not it is approved? If it does get approved, will it be available on its own or will it be used with other existing drugs? And what if one has failed the existing drugs? Thank you

Response from Dr. Boyle

Enfuvirtide (T-20) will likely be approved in the next few months. It must be used in combination with other antiretrovirals, i.e., in a "cocktail", otherwise resistance to T-20 develops quickly. Some patients who have "failed" the exisiting drugs, can still gain benefit from T-20 when it is used in combination with other antiretrovirals that are put together to form an "optimized background", but if there are no other drugs to support it, the beneficial effect is likely to be short lived.

Gabapentin & Neuropathy
IV drug administration

  • Email Email
  • Glossary Glossary



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint